OnePass entered a technology transfer agreement with Mayo Clinic
OnePass has entered into a know-how agreement with Mayo Clinic to deploy OnePass's patented technology for treating pancreatic cancer patients, employing multi-prong targeted chemotherapy directly to the tumor.
Comments